GR3005444T3 - - Google Patents

Info

Publication number
GR3005444T3
GR3005444T3 GR910402023T GR910402023T GR3005444T3 GR 3005444 T3 GR3005444 T3 GR 3005444T3 GR 910402023 T GR910402023 T GR 910402023T GR 910402023 T GR910402023 T GR 910402023T GR 3005444 T3 GR3005444 T3 GR 3005444T3
Authority
GR
Greece
Prior art keywords
antagonize
chem
compound
formula
effects
Prior art date
Application number
GR910402023T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005444T3 publication Critical patent/GR3005444T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR910402023T 1988-02-09 1992-08-20 GR3005444T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15386488A 1988-02-09 1988-02-09

Publications (1)

Publication Number Publication Date
GR3005444T3 true GR3005444T3 (el) 1993-05-24

Family

ID=22549061

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910402023T GR3005444T3 (el) 1988-02-09 1992-08-20

Country Status (6)

Country Link
EP (1) EP0328282B1 (el)
JP (1) JPH01265076A (el)
AT (1) ATE79540T1 (el)
DE (1) DE68902490T2 (el)
ES (1) ES2051996T3 (el)
GR (1) GR3005444T3 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795468A (en) * 1987-12-23 1989-01-03 Zimmer, Inc. Mechanism and method for locking a bearing insert to the base of a prosthetic implant
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
ES2391472T3 (es) * 2005-12-20 2012-11-27 Astrazeneca Ab Derivados de cinnolina sustituidos como moduladores del receptor de GABAA y método para su síntesis
TW200911760A (en) * 2007-06-19 2009-03-16 Astrazeneca Ab Compounds and uses thereof
WO2010123443A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
WO2010123440A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
WO2010123441A1 (en) * 2009-04-21 2010-10-28 Astrazeneca Ab Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders
WO2011021979A1 (en) * 2009-08-18 2011-02-24 Astrazeneca Ab Cinnoline compounds, their preparation, and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513639D0 (en) * 1985-05-30 1985-07-03 Ici America Inc Cinnoline compounds
WO1988007533A1 (en) * 1987-03-25 1988-10-06 Yoshitomi Pharmaceutical Industries, Ltd. Thienocinnoline compounds and their medicinal application

Also Published As

Publication number Publication date
EP0328282A3 (en) 1990-04-25
ATE79540T1 (de) 1992-09-15
DE68902490D1 (de) 1992-09-24
ES2051996T3 (es) 1994-07-01
EP0328282B1 (en) 1992-08-19
JPH01265076A (ja) 1989-10-23
DE68902490T2 (de) 1992-12-24
EP0328282A2 (en) 1989-08-16

Similar Documents

Publication Publication Date Title
AU4415285A (en) Benzodiazepine derivatives
GR3024255T3 (en) Benzo-fused lactams
GR3030718T3 (en) Novel prostaglandin analogue.
GR3005444T3 (el)
JPS6416781A (en) Cycloalkylamides of (8 beta)-1-alkyl-6- (substituted)ergoline
ATE75933T1 (de) Zahnaerztliche haftmittelzusammensetzung.
CA2012081A1 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
AU2051288A (en) Process for the synthesis of dimer alkaloid compounds
KR880700667A (ko) 정신병 치료제로서의 2,3-디히드로-1h-페날렌-2-아미노화합물
CS409584A2 (en) Herbicidni prostredek
ES8600759A1 (es) Procedimiento para preparar 2-(fenetil)-5-((3, 4-metilendioxi)- -hidroxibencil)-pirrolidina
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
PH24927A (en) Derivatives of substituted 1,2,3-thiadiazole-4-thiolate compounds